Media Database
>
Kevin Zitzman

Kevin Zitzman

Content Hub Project Manager at PRWeek

Contact this person
Email address
k*****@*******.comGet email address
Influence score
23
Phone
(XXX) XXX-XXXX Get mobile number
Location
United States
Languages
  • English
Covering topics
  • Public Relations

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

mmm-online.com

MM+M Podcast 8.23.22: Standing out despite the digital health downturn

Sheeza Hussain, chief commercial officer for remote patient monitoring firm Biofourmis, discusses commercial strategies in digital medicine during what’s been a relatively quiet investment period for health tech.
mmm-online.com

Doceree CEO discusses potential of data in digital marketing

Dr. Harshit Jain, a 2021 MM+M 40 Under 40 honoree, pressed marketers to remain open to how data can influence their work.
mmm-online.com

Data are no longer off-the-rack assets: They’re haute couture

Creating a path forward through creative and strategic data-based decisions.
mmm-online.com

Five things for pharma marketers to know: Monday, October 3, 2022

CDC says 3.2 million Americans got updated COVID boosters last week; FDA’s accelerated approval pathway faces criticism for pharma ties; Pfizer CEO pulls out of testifying to EU Parliament COVID panel.
mmm-online.com

Five things for pharma marketers to know: Tuesday, November 1, 2022

J&J decides to halt Phase I clinical trial of Essa Pharma’s prostate cancer drug; U.S. could have first RSV vaccine by 2023 season; Lebanon receives first cholera vaccines from France.
mmm-online.com

Five things for pharma marketers to know: Thursday, November 3, 2022

Vertex’s nonaddictive painkiller candidate shows promise as an alternative to opioids; New cancer drug prices rise 53% since 2017; Unity Biotechnology’s diabetic macular edema drug to move into pivotal study next year.
mmm-online.com

Q3 pharma earnings roundup: Moderna, Regeneron and Teva

Several other healthcare companies reported, including Agios, SpringWorks and Bausch Health.